Evidence map›Paper›PMID 35218585›Full record

ReviewBioFactors (Oxford, England)2022

Zinc and gut microbiota in health and gastrointestinal disease under the COVID-19 suggestion.

Emidio Scarpellini, Lukas M Balsiger, Valentina Maurizi, Emanuele Rinninella, Antonio Gasbarrini, Nena Giostra, Pierangelo Santori, Ludovico Abenavoli, Carlo Rasetti

Open access · greenAbstract readReview
In one paragraph

Review in BioFactors (Oxford, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Nutritional Support: The Use of Antioxidants in Inflammatory Bowel Disease.International journal of molecular sciences · 2024
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Emidio ScarpelliniHepatology and Internal Medicine Unit, "Madonna del soccorso" General Hospital, San Benedetto del Tronto, Italy.ORCID https://orcid.org/0000-0002-2101-1118
Lukas M BalsigerT.A.R.G.I.D, Gasthuisberg University Hospital, KULeuven, Lueven, Belgium.
Valentina MauriziInternal Medicine Residency Program, Università Politecnica delle Marche, Ancona, Italy.
Emanuele RinninellaClinical Nutrition Unit, Gastroenterology, Endocrinology, Nephrology and Urology Department, Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0002-9165-2367
Antonio GasbarriniInstitute of Medical Pathology, Catholic University of the Sacred Heart, Rome, Italy.
Nena GiostraHepatology and Internal Medicine Unit, "Madonna del soccorso" General Hospital, San Benedetto del Tronto, Italy.
Pierangelo SantoriHepatology and Internal Medicine Unit, "Madonna del soccorso" General Hospital, San Benedetto del Tronto, Italy.
Ludovico AbenavoliDepartment of Health Sciences, University "Magna Graecia", Catanzaro, Italy.
Carlo RasettiHepatology and Internal Medicine Unit, "Madonna del soccorso" General Hospital, San Benedetto del Tronto, Italy.
Università Cattolica del Sacro Cuore · ITUniversitair Ziekenhuis Leuven · BEMagna Graecia University · ITMarche Polytechnic University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microelements represent an emerging resource for medicine and its preventive branch. Zinc is the second most abundant element in our organism with peculiar physiologic functions and pathophysiologic implications in systemic and gastrointestinal (GI) diseases. It interacts very often with gut microbiota (GM) and can affect natural course of GI diseases through a bidirectional relationship with intestinal bugs. We aimed to review literature data regarding zinc chemistry, role in health, and GI diseases in man with a special focus on its interaction with GM. We conducted a search on the main medical databases for original articles, reviews, meta-analyses, randomized clinical trials and case series using the following keywords and acronyms and their associations: zinc, microelements, gut microbiota, gut health, and COVID-19. Zinc has a rapid and simple metabolism and limited storage within our body. Its efficacy on immune system modulation reflects on improved response to pathogens, reduced inflammatory response, and improved atopic/allergic reactions. Zinc is also involved in cell cycle regulation (namely, apoptosis) with potential anti-cancerogenic effects. All these effects are in a "symbiotic" relationship with GM. Finally, zinc shows preliminary viral antireplicative effects. Zinc seems to gain more and more evidences on its efficacy in allergic, atopic and infectious diseases treatment, and prevention. COVID-19 can be the booster for research on future applications of zinc as perfect "postbiotic" in medicine.

Indexed as

COVID-19Gastrointestinal DiseasesGastrointestinal MicrobiomeHumansImmunityZincZincCOVID-19gut healthgut microbiotamicroelementszinc

Identifiers

PMID35218585
PMCPMC9082519
OpenAlexW4214493370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.